ArticleBMC musculoskeletal disorders2025
TLR2 and IRF8 are the biomarkers associated with hypoxia in steroid-induced osteonecrosis of the femoral head via bioinformatics analysis and experimental validation.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccumulating evidence has shown that hypoxia harbors a dominant role in pathophysiological mechanisms of steroid-induced osteonecrosis of the femoral head (SONFH), but the significance of hypoxia in SONFH is still rarely explored.
methodsBy integrating SONFH gene expression matrix GSE123568 and hypoxia gene sets, the hypoxia-related differentially expressed genes (DEGs) were screened out. Functional and gene set enrichment analyses were conducted to reveal the underlying mechanisms of hypoxia-related DEGs. Protein and protein interaction (PPI) model was preformed to identify hub genes. The receiver operating characteristic (ROC) curve of hub genes was analyzed. Furthermore, the expression levels of hub genes were validated in clinical serum samples of SONFH patients and healthy volunteers.
resultsA total of 185 hypoxia-related DEGs were obtained between SONFH and non-SONFH controls. Functional and gene set enrichment analyses showed that those hypoxia-related DEGs are enriched in cytokine-cytokine receptor interaction, lipid and atherosclerosis, osteoclast differentiation, and HIF-1 signaling pathway. Depending on PPI network, we screened out five hub genes, including TLR2, IRF8, CXCL8, CD86, and MAPK1 which may serve as biomarkers for SONFH. The ROC results showed that all five hub genes had high diagnostic accuracy for patients with SONFH. The results of both qRT-PCR and enzyme-linked immunosorbent assay (ELISA) showed that TLR2 and IRF8 were markedly increased in blood samples of SONFH patients.
conclusionTLR2 and IRF8 might act as promising biomarkers for SONFH patients. The findings would offer new insights for identifying potential biomarkers and drug targets for SONFH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.